Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis
- 14 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (2), 468-475
- https://doi.org/10.1038/s41375-020-0926-6
Abstract
The expression of the CXCR4 chemokine receptor on CD34-positive blood cells is reduced in persons with primary myelofibrosis (PMF). We analyzed the relevance of cytofluorimetric assessment of the percentage of CD34-positive blood cells that had a positive CXCR4 surface expression (CD34/CXCR4-se) in a large cohort of subjects with myeloproliferative neoplasms. Mean CD34/CXCR4-se was lower in subjects with PMF compared with those with essential thrombocythemia (ET) or polycythemia vera (PV). A cutoff value of 39% was associated with a diagnosis of pre-fibrotic PMF vs. ET with a positive predictive value of 97%. In PMF male sex, older age, and MPL mutation were independent correlates of reduced CD34/CXCR4-se and associated with a briefer interval to development of severe anemia, large splenomegaly, thrombocytopenia, leukopenia, elevated CD34-positive blood cells, blast transformation and death. We constructed a prognostic model including age >65 years, hemoglobin < 100 g/L, CD34-positive blood cells > 50 × 106/L, and CD34/CXCR4-se <39% at diagnosis. The model identified three risk cohorts with greater accuracy compared with the International Prognostic Scoring System. In conclusion, CD34/CXCR4-se is a highly sensitive marker of disease activity and a new potential diagnostic and prognostic biomarker in PMF.This publication has 25 references indexed in Scilit:
- MPN-associated myelofibrosis (MPN-MF)Leukemia Research, 2011
- New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentBlood, 2009
- Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemiaBritish Journal of Haematology, 2008
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemiaBlood, 2008
- Hypermethylation ofCXCR4Promoter in CD34+ Cells from Patients with Primary MyelofibrosisThe International Journal of Cell Cloning, 2008
- Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1low mouse model of the diseaseExperimental Hematology, 2008
- Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosisBlood, 2007
- The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasiaBlood Cells, Molecules, and Diseases, 2007
- Anaemia characterises patients with myelofibrosis harbouring MplW515L/K mutationBritish Journal of Haematology, 2007
- Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)The International Journal of Cell Cloning, 2006